Showing results (191-200 of 483) with videos related to
Sort By:
Pageof 49
Disease Markers|August 1, 2012
SP-D polymorphisms and the risk of COPDTania A Shakoori, Don D Sin, S Nazim Hussain Bokhari, et al.Chest|July 23, 2013
Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbationsAlborz Hakimi Shoki, Nicole Mayer-Hamblett, Pearce G Wilcox, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|August 9, 2023
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysisElizabeth Guinto, Firoozeh V Gerayeli, Rachel L Eddy, et al.Expert Review of Respiratory Medicine|December 21, 2017
The role of beta-blockers in the management of chronic obstructive pulmonary diseaseFernando Sergio Leitao Filho, Nawaf M Alotaibi, Kei Yamasaki, et al.Chest|April 21, 2012
Relation between COPD severity and global cardiovascular risk in US adultsHwa Mu Lee, Janet Lee, Katherine Lee, et al.Chest|May 4, 2012
What to do when a smoker's CT scan is "normal"?: Implications for lung cancer screeningJoanna H Zurawska, Rachel Jen, Stephen Lam, et al.Respiratory Research|February 9, 2020
Sex differences in lymphoid follicles in COPD airwaysAnthony Tam, Naoya Tanabe, Andrew Churg, et al.Eclinicalmedicine|July 28, 2022
ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)Abdollah Safari, Amin Adibi, Don D Sin, et al.Scientific Reports|June 28, 2018
Severity of Airflow Obstruction and Work Loss in a Nationwide Population of Working AgeSun Hye Shin, Jihwan Park, Juhee Cho, et al.The European Respiratory Journal|August 29, 2020
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?Mohsen Sadatsafavi, James McCormack, John Petkau, et al.Pageof 49